Hennion & Walsh Asset Management’s Kura Oncology KURA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.07M | Buy |
185,930
+66,114
| +55% | +$381K | 0.04% | 479 |
|
|
2025
Q1 | $791K | Sell |
119,816
-3,099
| -3% | -$20.5K | 0.04% | 528 |
|
|
2024
Q4 | $1.07M | Sell |
122,915
-1,254
| -1% | -$10.9K | 0.05% | 448 |
|
|
2024
Q3 | $2.43M | Sell |
124,169
-3,450
| -3% | -$67.4K | 0.11% | 232 |
|
|
2024
Q2 | $2.63M | Sell |
127,619
-54,055
| -30% | -$1.11M | 0.14% | 200 |
|
|
2024
Q1 | $3.88M | Buy |
181,674
+54,031
| +42% | +$1.15M | 0.21% | 123 |
|
|
2023
Q4 | $1.84M | Buy |
127,643
+76,943
| +152% | +$1.11M | 0.1% | 258 |
|
|
2023
Q3 | $462K | Buy |
50,700
+2,013
| +4% | +$18.4K | 0.03% | 539 |
|
|
2023
Q2 | $515K | Sell |
48,687
-1,312
| -3% | -$13.9K | 0.03% | 501 |
|
|
2023
Q1 | $611K | Sell |
49,999
-1,581
| -3% | -$19.3K | 0.04% | 463 |
|
|
2022
Q4 | $640K | Buy |
51,580
+6,430
| +14% | +$79.8K | 0.04% | 443 |
|
|
2022
Q3 | $617K | Buy |
45,150
+11,242
| +33% | +$154K | 0.04% | 435 |
|
|
2022
Q2 | $622K | Buy |
+33,908
| New | +$622K | 0.04% | 442 |
|